Lynch H T, Lanspa S J, Boman B M, Smyrk T, Watson P, Lynch J F, Lynch P M, Cristofaro G, Bufo P, Tauro A V
Department of Preventive Medicine, Creighton Cancer Center, Omaha, Nebraska.
Gastroenterol Clin North Am. 1988 Dec;17(4):679-712.
HNPCC is an autosomal dominantly inherited disorder with proclivity to early onset colorectal cancer in the absence of multiple polyps of the colon. There is a predilection for proximal colonic location (70 per cent) and an excess of synchronous and metachronous colorectal cancers. HNPCC is subdivided into Lynch syndrome I, which is restricted to site-specific colon cancer susceptibility, and Lynch syndrome II, which shows all of the features of Lynch syndrome I, but in addition, patients are at inordinately increased risk for carcinoma of the endometrium, ovary, and other anatomic sites. The frequency of HNPCC is conservatively estimated to be 4 to 6 per cent of the total colorectal cancer burden. Because of the fact that the family history is underreported almost uniformly in medical practice, we believe that the true frequency of this disease may be much greater. Heterogeneity may be extant with respect to tumor association, in that in certain Lynch syndrome II kindreds, carcinoma of the pancreas, kidney, breast, and other anatomic sites may predominate. Knowledge of the natural history of HNPCC predicates surveillance and management strategies. Thus, because of the early onset of and proximal predilection for colorectal cancer, we recommend initiation of colonscopy at age 25 and annually thereafter. We also recommend guaiac testing of the stool at least twice a year. In the case of Lynch syndrome II, in addition to colonscopy, we recommend intensive surveillance for the endometrium, including aspiration biopsies. Other targeted organs, depending on the tumor spectrum in the family, should be given priority attention. Because of an excess of synchronous and metachronous colorectal cancer in HNPCC, subtotal colectomy with ileorectal anastomosis is the treatment of choice for initial colorectal cancer. In women presenting with initial colorectal cancer who have completed their families, consideration should be given to prophylactic hysterectomy and bilateral salpingo-oophorectomy at the time of surgery for colorectal cancer. Needed are biomarkers of acceptable sensitivity and specificity for the genotype, because HNPCC lacks premonitory physical signs. We believe that increased knowledge about colorectal cancer etiology and carcinogenesis can be attained through the study of families prone to the Lynch syndromes.
遗传性非息肉病性结直肠癌(HNPCC)是一种常染色体显性遗传性疾病,在无结肠多发息肉的情况下易患早发性结直肠癌。其好发于近端结肠(70%),同时发生和异时发生的结直肠癌较多。HNPCC可分为林奇综合征I型,其仅限于特定部位的结肠癌易感性;以及林奇综合征II型,其具有林奇综合征I型的所有特征,但此外,患者患子宫内膜癌、卵巢癌及其他解剖部位癌症的风险极高。据保守估计,HNPCC在所有结直肠癌负担中所占比例为4%至6%。由于在医疗实践中家族史几乎普遍未得到充分报告,我们认为这种疾病的实际发病率可能更高。在肿瘤关联方面可能存在异质性,因为在某些林奇综合征II型家族中,胰腺癌、肾癌、乳腺癌及其他解剖部位的癌症可能更为常见。了解HNPCC的自然病史有助于制定监测和管理策略。因此,鉴于结直肠癌发病早且好发于近端结肠,我们建议在25岁时开始进行结肠镜检查,此后每年进行一次。我们还建议每年至少进行两次粪便隐血试验。对于林奇综合征II型,除结肠镜检查外,我们建议对子宫内膜进行强化监测,包括吸取活检。其他有针对性的器官,根据家族中的肿瘤谱,应给予优先关注。由于HNPCC中同时发生和异时发生的结直肠癌较多,次全结肠切除术加回肠直肠吻合术是初发性结直肠癌的首选治疗方法。对于已完成生育的初发性结直肠癌女性患者,在进行结直肠癌手术时,应考虑预防性子宫切除术和双侧输卵管卵巢切除术。由于HNPCC缺乏先兆体征,因此需要具有可接受的敏感性和特异性的基因型生物标志物。我们认为,通过对易患林奇综合征的家族进行研究,可以增加对结直肠癌病因和致癌机制的了解。